Byung Jin Kim1, Dae Chul Seo1, Bum Soo Kim1, Jin Ho Kang1. 1. Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine.
Abstract
BACKGROUND: The relationship between chronic smoking and hypertension (HTN) is inconclusive in previous studies, which were mainly based on self-reported smoking status. The aim of this study was to evaluate the association of cotinine-verified smoking status with incident HTN.Methods and Results: A total of 74,743 participants (43,104 men; age 38±5.4 years) were included in the study, with a mean follow-up period of 29 months. Individuals were divided into 4 groups on the basis of their cotinine-verified smoking status at baseline and at follow-up (never-smoking, new-smoking, former-smoking, and sustained-smoking). The incidence rate of HTN in the never-smoking, new-smoking, former-smoking, and sustained-smoking groups was 8.2%, 7.6%, 10.1%, and 8.7% for men and 1.8%, 2.5%, 1.5%, and 2.2% for women, respectively. In a multivariate Cox-hazard regression analysis adjusted for the variables with a univariate relationship, new-smoking and sustained-smoking had decreased relative risks (RRs) for incident HTN compared with never-smoking (RR [95% CI], 0.75 [0.58, 0.96] for new-smoking and 0.82 [0.74, 0.90] for sustained-smoking). Cotinine-verified current smoking at baseline was also inversely associated with incident HTN compared with cotinine-verified never-smoking at baseline (0.91 [0.84, 0.98]). These results remained significant only in men, although there was no sex interaction. CONCLUSIONS: This longitudinal study showed that cotinine-verified new-smoking and sustained-smoking decreased the risk for incident HTN, especially in men, compared with never-smoking.
BACKGROUND: The relationship between chronic smoking and hypertension (HTN) is inconclusive in previous studies, which were mainly based on self-reported smoking status. The aim of this study was to evaluate the association of cotinine-verified smoking status with incident HTN.Methods and Results: A total of 74,743 participants (43,104 men; age 38±5.4 years) were included in the study, with a mean follow-up period of 29 months. Individuals were divided into 4 groups on the basis of their cotinine-verified smoking status at baseline and at follow-up (never-smoking, new-smoking, former-smoking, and sustained-smoking). The incidence rate of HTN in the never-smoking, new-smoking, former-smoking, and sustained-smoking groups was 8.2%, 7.6%, 10.1%, and 8.7% for men and 1.8%, 2.5%, 1.5%, and 2.2% for women, respectively. In a multivariate Cox-hazard regression analysis adjusted for the variables with a univariate relationship, new-smoking and sustained-smoking had decreased relative risks (RRs) for incident HTN compared with never-smoking (RR [95% CI], 0.75 [0.58, 0.96] for new-smoking and 0.82 [0.74, 0.90] for sustained-smoking). Cotinine-verified current smoking at baseline was also inversely associated with incident HTN compared with cotinine-verified never-smoking at baseline (0.91 [0.84, 0.98]). These results remained significant only in men, although there was no sex interaction. CONCLUSIONS: This longitudinal study showed that cotinine-verified new-smoking and sustained-smoking decreased the risk for incident HTN, especially in men, compared with never-smoking.
Authors: Ji Hye Kim; Dae Chul Seo; Byung Jin Kim; Jeong Gyu Kang; Seung Jae Lee; Sung Ho Lee; Bum Soo Kim; Jin Ho Kang Journal: Diabetes Metab J Date: 2019-11-01 Impact factor: 5.376
Authors: Yongho Jee; Jooeun Jeon; Joung Hwan Back; Mikyung Ryu; Sung-Il Cho Journal: Int J Environ Res Public Health Date: 2019-06-24 Impact factor: 3.390
Authors: Byung Jin Kim; Jeong Gyu Kang; Ji Hye Kim; Dae Chul Seo; Ki Chul Sung; Bum Soo Kim; Jin Ho Kang Journal: J Clin Med Date: 2019-08-16 Impact factor: 4.241
Authors: Jaime Butler-Dawson; Lyndsay Krisher; Miranda Dally; Katherine A James; Richard J Johnson; Diana Jaramillo; Hillary Yoder; Evan C Johnson; Daniel Pilloni; Claudia Asensio; Alex Cruz; Lee S Newman Journal: Kidney Int Rep Date: 2021-06-22
Authors: Robert C Kaplan; Pedro L Baldoni; Garrett M Strizich; Eliseo J Pérez-Stable; Nancy L Saccone; Carmen A Peralta; Krista M Perreira; Marc D Gellman; Jessica S Williams-Nguyen; Carlos J Rodriguez; David J Lee; Martha Daviglus; Gregory A Talavera; James P Lash; Jianwen Cai; Nora Franceschini Journal: Am J Hypertens Date: 2021-03-11 Impact factor: 2.689